Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

NCT00962507 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm

Interventions

DRUG: everolimus
DRUG: panobinostat
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

City of Hope Medical Center

Collaborators

[object Object]